Literature DB >> 27414155

Chronic Kidney Disease Class Predicts Mortality After Abdominal Aortic Aneurysm Repair in Propensity-matched Cohorts From the Medicare Population.

Nathan J Aranson1, Robert T Lancaster, Emel A Ergul, Mark F Conrad, Glenn M LaMuraglia, Christopher J Kwolek, Richard P Cambria, Virendra I Patel.   

Abstract

INTRODUCTION: Chronic kidney disease (CKD) predicts mortality after abdominal aortic aneurysm (AAA) repair. Few studies are adequately powered to stratify outcomes by CKD severity. This study assesses the effect of CKD severity on survival after AAA repair.
METHODS: Patients who underwent AAA repair from 2006 to 2007 were retrospectively identified in the Medicare database and stratified by CKD class as follows: normal (CKD class 1 and 2), moderate (CKD class 3), and severe (CKD class 4 and 5). Propensity matching (30:1) by clinical factors and procedure type was performed to derive well-matched comparative cohorts. Primary outcomes were 30-day and long-term mortality; secondary outcomes included hospital length of stay and cost.
RESULTS: A total of 47,715 patients were included (96.7% normal, 1.88% moderate, and 1.65% severe). Propensity matching was corrected for differences between cohorts. Thirty-day mortality was higher in moderate (5.7% vs normal 2.5%; P < 0.01) and severe (9.9% vs normal 1.8%; P < 0.01) groups. Hospital length of stay increased with CKD severity (4.4 ± 3.7 days normal vs 6.5 ± 4.2 days moderate CKD; P < 0.01/4.7 ± 3.8 days normal vs 9.1 ± 4.5 days severe CKD; P < 0.01) as did cost ($23 ± 14K normal vs $25 ± 16K moderate; P < 0.01 /$22 ± 11K normal vs $29 ± 22K severe; P < 0.01). Three-year survival favored the normal cohort (80% vs 64% moderate; log rank P < 0.01 /82% normal vs 44% severe; log rank P < 0.01).
CONCLUSIONS: CKD severity is an important predictor of perioperative mortality and long-term survival after AAA repair in propensity-matched cohorts. The 5-fold increase in 30-day mortality and 44% in 3-year survival suggest that elective AAA repair is contraindicated in most severe CKD patients.

Entities:  

Mesh:

Year:  2016        PMID: 27414155     DOI: 10.1097/SLA.0000000000001519

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial.

Authors:  Mel S Lee; Fan-Yen Lee; Yung-Lung Chen; Pei-Hsun Sung; Hsin-Ju Chiang; Kuan-Hung Chen; Tien-Hung Huang; Yi-Ling Chen; John Y Chiang; Tsung-Cheng Yin; Hsueh-Wen Chang; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-03-14

2.  Intrarenal arterial administration of human umbilical cord-derived mesenchymal stem cells effectively preserved the residual renal function of diabetic kidney disease in rat.

Authors:  Fanna Liu; Hon-Kan Yip; Ya Yue; Jui-Ning Yeh; John Y Chiang; Pei-Hsun Sung; Yi-Ling Chen
Journal:  Stem Cell Res Ther       Date:  2022-05-07       Impact factor: 8.079

3.  Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Pantelis Sarafidis; Sven Martens; Athanasios Saratzis; Daniella Kadian-Dodov; Patrick T Murray; Catherine M Shanahan; Allen D Hamdan; Daniel T Engelman; Ulf Teichgräber; Charles A Herzog; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Holger Reinecke; Kirsten Johansen
Journal:  Cardiovasc Res       Date:  2022-09-20       Impact factor: 13.081

4.  Late outcomes of endovascular aortic stent graft therapy in patients with chronic kidney disease.

Authors:  Chung-Cheng Wu; An-Hsun Chou; Yu-Sheng Lin; Victor Chien-Chia Wu; Shang-Hung Chang; Pao-Hsien Chu; Yu-Ting Cheng; Po-Jen Ko; Kuo-Sheng Liu; Shao-Wei Chen
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

5.  Overexpression of miR-19a and miR-20a in iPS-MSCs preserves renal function of chronic kidney disease with acute ischaemia-reperfusion injury in rat.

Authors:  Mel S Lee; Hon-Kan Yip; Chih-Chao Yang; John Y Chiang; Tien-Hung Huang; Yi-Chen Li; Kuan-Hung Chen; Pei-Hsun Sung
Journal:  J Cell Mol Med       Date:  2021-06-23       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.